$SYRE
Spyre Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$90.25
▼-2.62%-$2.43
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSpyre Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SYRE down today? It is at $90.25 (-2.62%), and our scanner flagged it 120 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SYRE spikes, and full due diligence on SYRE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SYRE 120 times in the last 30 days. Create a free account to track $SYRE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on SYRE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SYRE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Burrows Scott L Officer | Sold (automatic/other) | -18K 0.02% of company | sold 19% | 80K | $1.6M at $89.35 | Sep 2, 26 |
King-Jones Heidy Officer | Sold (automatic/other) | -400 | sold 12% | 3K | $36K at $90.00 | Sep 2, 26 |
King-Jones Heidy Officer | Other | 400 | added 14% | 3K | $6K at $14.50 | Sep 2, 26 |
Turtle Cameron Officer | Sold (automatic/other) | -15K 0.02% of company | sold 2.6% | 553K | $1.3M at $86.36 | Sep 1, 26 |
Burrows Scott L Officer | Sold (automatic/other) | -8K | sold 7.1% | 98K | $647K at $86.25 | Sep 1, 26 |
Burrows Scott L Officer | Other | 8K | added 7.7% | 105K | $109K at $14.50 | Sep 1, 26 |
King-Jones Heidy Officer | Sold (automatic/other) | -28K 0.03% of company | sold 91% | 3K | $2.4M at $86.40 | Sep 1, 26 |
King-Jones Heidy Officer | Other | 28K 0.03% of company | added 100% | 31K | $406K at $14.50 | Sep 1, 26 |
Albers Jeffrey W. Director | Sold (automatic/other) | -5K | n/a | n/a | $522K at $104.47 | Aug 7, 26 |
Albers Jeffrey W. Director | Sold (automatic/other) | -18K 0.02% of company | sold 66% | 9K | $1.9M at $104.38 | Aug 7, 26 |
Albers Jeffrey W. Director | Other | 5K | n/a | 5K | $52K at $10.39 | Aug 7, 26 |
Turtle Cameron Officer | Sold (automatic/other) | -15K 0.02% of company | sold 2.6% | 568K | $1.4M at $93.97 | Aug 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on SYRE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for SYRE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
SYRE last traded at $90.25, down 2.62% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Spyre Therapeutics, Inc. Common Stock (SYRE) is next expected to report earnings on Tuesday, November 3, 2026, about 44 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SYRE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SYRE 120 times in the last 30 days.
SYRE (Spyre Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $7.96B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SYRE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SYRE discussion
Sign in to ask a question or join the discussion.